Focus on the cetirizine use in clinical practice: a reappraisal 30 years later

Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine belongs...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsico, Angelo G., Leonardi, Salvatore, Licari, Amelia, Marseglia, Gianluigi, Miraglia del Giudice, Michele, Peroni, Diego G., Salpietro, Carmelo, Ciprandi, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898951/
https://www.ncbi.nlm.nih.gov/pubmed/31827796
http://dx.doi.org/10.1186/s40248-019-0203-6
_version_ 1783477063475265536
author Corsico, Angelo G.
Leonardi, Salvatore
Licari, Amelia
Marseglia, Gianluigi
Miraglia del Giudice, Michele
Peroni, Diego G.
Salpietro, Carmelo
Ciprandi, Giorgio
author_facet Corsico, Angelo G.
Leonardi, Salvatore
Licari, Amelia
Marseglia, Gianluigi
Miraglia del Giudice, Michele
Peroni, Diego G.
Salpietro, Carmelo
Ciprandi, Giorgio
author_sort Corsico, Angelo G.
collection PubMed
description Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine belongs to the second-generation family, so, it is very selective for peripheral H1 receptors, is potent and quickly relieves symptoms, exerts additional anti-allergic/anti-inflammatory effects, and is usually well-tolerated. It has been marketed 30 years ago. In these years, a remarkable body of evidence has been built. The current review provides a practical update on the use of cetirizine in clinical practice.
format Online
Article
Text
id pubmed-6898951
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68989512019-12-11 Focus on the cetirizine use in clinical practice: a reappraisal 30 years later Corsico, Angelo G. Leonardi, Salvatore Licari, Amelia Marseglia, Gianluigi Miraglia del Giudice, Michele Peroni, Diego G. Salpietro, Carmelo Ciprandi, Giorgio Multidiscip Respir Med Review Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine belongs to the second-generation family, so, it is very selective for peripheral H1 receptors, is potent and quickly relieves symptoms, exerts additional anti-allergic/anti-inflammatory effects, and is usually well-tolerated. It has been marketed 30 years ago. In these years, a remarkable body of evidence has been built. The current review provides a practical update on the use of cetirizine in clinical practice. BioMed Central 2019-12-06 /pmc/articles/PMC6898951/ /pubmed/31827796 http://dx.doi.org/10.1186/s40248-019-0203-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Corsico, Angelo G.
Leonardi, Salvatore
Licari, Amelia
Marseglia, Gianluigi
Miraglia del Giudice, Michele
Peroni, Diego G.
Salpietro, Carmelo
Ciprandi, Giorgio
Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_full Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_fullStr Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_full_unstemmed Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_short Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
title_sort focus on the cetirizine use in clinical practice: a reappraisal 30 years later
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898951/
https://www.ncbi.nlm.nih.gov/pubmed/31827796
http://dx.doi.org/10.1186/s40248-019-0203-6
work_keys_str_mv AT corsicoangelog focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT leonardisalvatore focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT licariamelia focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT marsegliagianluigi focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT miragliadelgiudicemichele focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT peronidiegog focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT salpietrocarmelo focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater
AT ciprandigiorgio focusonthecetirizineuseinclinicalpracticeareappraisal30yearslater

Ejemplares similares